TUCSON, Ariz.--(BUSINESS WIRE)--HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) system and service partner for the life sciences industry, today introduced the M3® Series, the industry’s first multiplexed mini-microarray solution for biomarker discovery and gene profiling. The M3 series allows researchers to monitor the behavior of multiple genes in the same sample, simplifying experiments and lowering costs. The platform is based on HTG’s proven qNPA ArrayPlate technology, which allows researchers to investigate a customized set of genes with greater precision than traditional microarrays.
